ATLANTIC INTERNATIONAL CORP (ATLN) Fundamental Analysis & Valuation

NASDAQ:ATLN • US0485921094

Current stock price

3.2 USD
-0.15 (-4.48%)
At close:
3.2 USD
0 (0%)
After Hours:

This ATLN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ATLN Profitability Analysis

1.1 Basic Checks

  • ATLN had negative earnings in the past year.
  • ATLN had a positive operating cash flow in the past year.
  • ATLN had negative earnings in each of the past 5 years.
  • ATLN had a negative operating cash flow in each of the past 5 years.
ATLN Yearly Net Income VS EBIT VS OCF VS FCFATLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -91.54%, ATLN is doing worse than 92.86% of the companies in the same industry.
Industry RankSector Rank
ROA -91.54%
ROE N/A
ROIC N/A
ROA(3y)-95.29%
ROA(5y)-94.51%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATLN Yearly ROA, ROE, ROICATLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

  • With a Gross Margin value of 10.85%, ATLN is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of ATLN has declined.
  • ATLN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-47.23%
GM growth 5Y-28.86%
ATLN Yearly Profit, Operating, Gross MarginsATLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ATLN Health Analysis

2.1 Basic Checks

  • ATLN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ATLN has been increased compared to 1 year ago.
  • The number of shares outstanding for ATLN has been increased compared to 5 years ago.
  • Compared to 1 year ago, ATLN has a worse debt to assets ratio.
ATLN Yearly Shares OutstandingATLN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ATLN Yearly Total Debt VS Total AssetsATLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • ATLN has an Altman-Z score of 2.17. This is not the best score and indicates that ATLN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.17, ATLN is in line with its industry, outperforming 57.14% of the companies in the same industry.
  • ATLN has a debt to FCF ratio of 23.22. This is a negative value and a sign of low solvency as ATLN would need 23.22 years to pay back of all of its debts.
  • ATLN's Debt to FCF ratio of 23.22 is in line compared to the rest of the industry. ATLN outperforms 57.14% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 23.22
Altman-Z 2.17
ROIC/WACCN/A
WACC12.08%
ATLN Yearly LT Debt VS Equity VS FCFATLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

  • ATLN has a Current Ratio of 1.23. This is a normal value and indicates that ATLN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.23, ATLN is doing worse than 83.93% of the companies in the same industry.
  • ATLN has a Quick Ratio of 1.23. This is a normal value and indicates that ATLN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.23, ATLN is doing worse than 76.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.23
ATLN Yearly Current Assets VS Current LiabilitesATLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ATLN Growth Analysis

3.1 Past

  • ATLN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.05%, which is quite impressive.
  • ATLN shows a strong growth in Revenue. In the last year, the Revenue has grown by 42.26%.
  • Measured over the past years, ATLN shows a very strong growth in Revenue. The Revenue has been growing by 284.02% on average per year.
EPS 1Y (TTM)64.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.69%
Revenue 1Y (TTM)42.26%
Revenue growth 3Y1182.14%
Revenue growth 5Y284.02%
Sales Q2Q%2.16%

3.2 Future

  • The Earnings Per Share is expected to grow by 2.32% on average over the next years.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-25%
EPS Next 2Y2.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ATLN Yearly Revenue VS EstimatesATLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2024 2025 2026 100M 200M 300M 400M
ATLN Yearly EPS VS EstimatesATLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

1

4. ATLN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ATLN. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ATLN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATLN Price Earnings VS Forward Price EarningsATLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • ATLN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 73.09
EV/EBITDA N/A
ATLN Per share dataATLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.32%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ATLN Dividend Analysis

5.1 Amount

  • No dividends for ATLN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ATLN Fundamentals: All Metrics, Ratios and Statistics

ATLANTIC INTERNATIONAL CORP

NASDAQ:ATLN (3/27/2026, 8:01:27 PM)

After market: 3.2 0 (0%)

3.2

-0.15 (-4.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)03-26
Earnings (Next)N/A
Inst Owners2.31%
Inst Owner Change0.03%
Ins Owners48.16%
Ins Owner Change22.31%
Market Cap240.42M
Revenue(TTM)445.38M
Net Income(TTM)-100.93M
Analysts85.71
Price Target6.12 (91.25%)
Short Float %3.67%
Short Ratio0.9
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.54
P/FCF 73.09
P/OCF 71.61
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2
EYN/A
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)0.04
FCFY1.37%
OCF(TTM)0.04
OCFY1.4%
SpS5.93
BVpS-0.29
TBVpS-0.66
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -91.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.85%
FCFM 0.74%
ROA(3y)-95.29%
ROA(5y)-94.51%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-47.23%
GM growth 5Y-28.86%
F-Score5
Asset Turnover4.04
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 23.22
Debt/EBITDA N/A
Cap/Depr 1.38%
Cap/Sales 0.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.23
Altman-Z 2.17
F-Score5
WACC12.08%
ROIC/WACCN/A
Cap/Depr(3y)29.06%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.69%
EPS Next Y-25%
EPS Next 2Y2.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)42.26%
Revenue growth 3Y1182.14%
Revenue growth 5Y284.02%
Sales Q2Q%2.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-90.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-183.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y168.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y170.92%
OCF growth 3YN/A
OCF growth 5YN/A

ATLANTIC INTERNATIONAL CORP / ATLN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ATLANTIC INTERNATIONAL CORP (ATLN) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ATLN.


What is the valuation status for ATLN stock?

ChartMill assigns a valuation rating of 1 / 10 to ATLANTIC INTERNATIONAL CORP (ATLN). This can be considered as Overvalued.


Can you provide the profitability details for ATLANTIC INTERNATIONAL CORP?

ATLANTIC INTERNATIONAL CORP (ATLN) has a profitability rating of 0 / 10.


What is the financial health of ATLANTIC INTERNATIONAL CORP (ATLN) stock?

The financial health rating of ATLANTIC INTERNATIONAL CORP (ATLN) is 2 / 10.


What is the earnings growth outlook for ATLANTIC INTERNATIONAL CORP?

The Earnings per Share (EPS) of ATLANTIC INTERNATIONAL CORP (ATLN) is expected to decline by -25% in the next year.